Hoskins
said that the council has not yet decided what exactly the pharmacare
system will look like — such as whether it will maintain a combined
public-private coverage system and how it will work. “I know everybody
is anxious to see the final report. I’m anxious to get it done as well.”

Longtime
pharmacare advocate Linda Silas called the interim report “promising.”
Silas, who is president of the Canadian Federation of Nurses Unions,
said she was particularly pleased by the inclusion of an evidence-based
national drug formulary.